Barclays PLC Seres Therapeutics, Inc. Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 70,756 shares of MCRB stock, worth $50,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,756

Previous 135,178 47.66%

Holding current value

$50,944

Previous $189,000 70.9%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.75 - $1.56 $48,316 - $100,498	-64,422 Reduced 47.66%	70,756 $55,000
Q4 2023 Feb 15, 2024	SELL	$0.93 - $2.15 $303,208 - $700,966	-326,031 Reduced 70.69%	135,178 $189,000
Q3 2023 Nov 07, 2023	BUY	$2.33 - $5.07 $210,408 - $457,841	90,304 Added 24.35%	461,209 $1.1 Million
Q2 2023 Aug 03, 2023	BUY	$4.67 - $6.55 $1.22 Million - $1.71 Million	260,845 Added 237.0%	370,905 $1.78 Million
Q1 2023 May 04, 2023	SELL	$4.95 - $6.09 $329,714 - $405,648	-66,609 Reduced 37.7%	110,060 $624,000

Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $97,188 - $172,800	19,094 Added 12.12%	176,669 $989,000
Q3 2022 Nov 03, 2022	BUY	$3.5 - $7.2 $416,804 - $857,426	119,087 Added 309.41%	157,575 $1.01 Million
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $53,597 - $151,264	19,851 Added 106.51%	38,488 $132,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $1.53 Million - $2.15 Million	-243,062 Reduced 92.88%	18,637 $132,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $1.29 Million - $2.44 Million	213,765 Added 445.96%	261,699 $2.18 Million
Q3 2021 Nov 09, 2021	BUY	$5.46 - $22.6 $128,703 - $532,727	23,572 Added 96.76%	47,934 $334,000
Q2 2021 Aug 13, 2021	SELL	$18.46 - $24.36 $565,854 - $746,707	-30,653 Reduced 55.72%	24,362 $582,000
Q1 2021 May 13, 2021	BUY	$17.66 - $28.92 $554,100 - $907,393	31,376 Added 132.73%	55,015 $1.13 Million
Q4 2020 Feb 11, 2021	SELL	$23.25 - $37.73 $157,821 - $256,111	-6,788 Reduced 22.31%	23,639 $578,000
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $8,314 - $63,889	2,223 Added 7.88%	30,427 $862,000
Q2 2020 Aug 12, 2020	BUY	$3.04 - $6.2 $48,907 - $99,745	16,088 Added 132.78%	28,204 $135,000
Q1 2020 May 13, 2020	SELL	$2.64 - $3.82 $64,476 - $93,295	-24,423 Reduced 66.84%	12,116 $43,000
Q4 2019 Feb 10, 2020	BUY	$2.99 - $4.42 $50,237 - $74,264	16,802 Added 85.13%	36,539 $126,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $12,086 - $21,956	5,278 Added 36.5%	19,737 $79,000
Q2 2019 Aug 14, 2019	BUY	$2.28 - $7.35 $18,657 - $60,145	8,183 Added 130.39%	14,459 $47,000
Q1 2019 May 15, 2019	BUY	$4.83 - $7.21 $29,226 - $43,627	6,051 Added 2689.33%	6,276 $43,000
Q4 2018 Feb 14, 2019	SELL	$4.52 - $8.88 $34,505 - $67,789	-7,634 Reduced 97.14%	225 $1,000
Q3 2018 Nov 14, 2018	BUY	$7.33 - $9.23 $40,710 - $51,263	5,554 Added 240.95%	7,859 $60,000
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $36,512 - $50,462	-5,284 Reduced 69.63%	2,305 $20,000
Q1 2018 May 15, 2018	SELL	$7.34 - $11.16 $173,635 - $264,000	-23,656 Reduced 75.71%	7,589 $56,000
Q4 2017 Feb 14, 2018	SELL	$9.15 - $12.64 $104,346 - $144,146	-11,404 Reduced 26.74%	31,245 $317,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $546,333 - $718,635	42,649	42,649 $684,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account